Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$12.7 Million
27/02/2025 07:27
Feb 27 (Reuters) - PYC Therapeutics Ltd PYC.AX: HY REVENUES FROM ORDINARY ACTIVITIES A$12.7 MILLION LOSS FOR THE HALF-YEAR ATTRIBUTABLE A$25.6 MILLION Source text: ID:nASXF7QC5 Further company coverage: PYC.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on PYC Therapeutics
See all newsAustralia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million
Brief: PYC Therapeutics Seeks Trading Halt
Brief: PYC Therapeutics Says Rohan Hockings Re-Appointed As Managing Director